GIE Associate Editor Monique Barakat, MD, highlights this article from the October issue: “Endoscopic ultrasound–guided radiofrequency ablation for intraductal papillary mucinous neoplasms with worrisome features: long-term outcomes in nonsurgical patients (with video)” by Julien Barras, MD, et al. Earlier EUS-guided ablation series largely excluded pancreatic cysts with worrisome features, which is precisely why they could …
Tag: intraductal papillary mucinous neoplasm
HMGA2 protein as a biomarker of dysplasia in IPMN
Christopher J. DiMaio, MD, FASGE, from the Icahn School of Medicine at Mount Sinai, Mount Sinai Medical Center, in New York, New York, USA discusses his article "Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm." No reliable cyst fluid biomarkers exist that …
Continue reading HMGA2 protein as a biomarker of dysplasia in IPMN
